http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1283054-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c9bdad784b22adc0755666ee6856eff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06ea01499eb8f06c8a40f34d10091a6e |
| publicationDate | 2003-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1283054-A1 |
| titleOfInvention | Drugs for complications of diabetes and neuropathy and utilization thereof |
| abstract | There are provided a medicament excellent in prevention,nimprovement, treatment, etc. of a diabetic complication, andna medicament excellent in prevention, improvement, treatment,netc. of a neuropathy, each using a postprandial bloodnsugar-lowering agent as an effective ingredient therefor.nParticularly, D-phenylalanine derivatives such as nateglinidenare useful as an oral medicine. n According to the present invention, these excellentnmedicaments, a method for use thereof (a method fornadministration thereof to a living subject in the aboventreatment, etc.), and a use of the postprandial bloodnsugar-lowering agent for production of the said medicaments,nand the like are provided. At least one agent selected fromnan antihypertensive agent, a vasodilating agent and annanti-hyperlipidemic agent may be used at the same time with thenpostprandial blood sugar-lowering agent, by mixing further suchnat least one agent selected from an antihypertensive agent, anvasodilating agent and an anti-hyperlipidemic agent in (with)nsuch above medicament or by combining them for concomitant use,nwhereby the effect for prevention, improvement, treatment, etc.nof the diabetic complication described above can be enhancednmuch more. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013115739-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013115740-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2387054-A1 |
| priorityDate | 2000-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 500.